Brief: Vera Therapeutics FY EPS USD -2.25
20/03/2024 11:30
Mar 20 (Reuters) - Vera Therapeutics FY operating income USD -102.012 million. * FY operating expenses USD 102.012 million * FY net income USD -95.99 million
Recent news on Vera Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Sysco
Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial